| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 10/29/2008 | CN101292952A Glycyrrhizic acid, biogastrone acid or its salt, derivative temperature sensing gel rubber, preparation method and application thereof |
| 10/29/2008 | CN101292951A Recombined human vascellum esoderma inhibin durative action preparation, preparation method and application thereof |
| 10/29/2008 | CN101292950A Beta carotene solid dispersion and prepraring method thereof |
| 10/29/2008 | CN101292942A Dermatologic preparation composition containing gamma-oryzanol |
| 10/29/2008 | CN100429297C Marigold lutein supercritical CO2 extraction method |
| 10/29/2008 | CN100428960C Method for preparing nano liver-target biodegradating medicine carrier material |
| 10/29/2008 | CN100428959C Process for producing drug ultramicroparticle and apparatus therefor |
| 10/29/2008 | CN100428957C A fibroid magnetic medicament and preparation method thereof |
| 10/29/2008 | CN100428935C Abiduoer granular formulation |
| 10/29/2008 | CN100428931C Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method |
| 10/29/2008 | CN100428926C Orally disintegrating tablets and process for obtaining them |
| 10/29/2008 | CN100428923C External use composition |
| 10/28/2008 | USRE40555 Preparation of agarose coated, solid agarose beads containing secretory cells |
| 10/28/2008 | US7442788 Nucleosides; peptide nucleic acids; orientation of sugar governs positioning of antisense molecule |
| 10/28/2008 | US7442764 Reversible modification of amine-containing compounds |
| 10/28/2008 | US7442721 biocompatible durable controlled drug releasing polymeric coatings for medical devices. The drug release rates of the polymers are controlled by adjusting monomer ratios and glass transition temperatures Tgs. The polymers are durable; they do not delaminate from the coated medical device. |
| 10/28/2008 | US7442711 Amelioration of the development of cataracts and other ophthalmic diseases |
| 10/28/2008 | US7442686 Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions |
| 10/28/2008 | US7442684 A hormone or growth factor subunit and a half-life-increasing moiety are covalently bound; increasing fertility, egg production, spermatogenesis and vascularization; especially VEGF-FSH with increased serum half lives |
| 10/28/2008 | US7442682 disclosed for the treatment of diabetes and related diseases using peptides with incretin hormone activity. Preferably, the peptide with incretin hormone activity is GLP-1, exendin or an analog of GLP-1 or exendin. The peptides with incretin hormone activity are administered transepithelially hormones |
| 10/28/2008 | US7442541 biologically pure strain of Aureobasidium pullulans isolated from a food source; culturing in a medium containing saccharides as a carbon source; has resistance to the antibiotic cycloheximide |
| 10/28/2008 | US7442524 Conjugate comprising polypeptide with N-glycosylation site and sugar; increase blood clot formation for treatment of thrombocytopenia and hemophilia |
| 10/28/2008 | US7442388 For administered via inhalation, dispersibility and storage stability |
| 10/28/2008 | US7442387 Pharmaceutical composition for controlled release of active substances and manufacturing method thereof |
| 10/28/2008 | US7442386 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
| 10/28/2008 | US7442383 N-methyl D-aspartic acid (NMDA) receptor antagonism; neuroprotection |
| 10/28/2008 | US7442370 Polymer conjugates of mutated neublastin |
| 10/28/2008 | US7442369 Compositions of minoxidil |
| 10/28/2008 | US7442368 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 10/28/2008 | CA2556514C Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same |
| 10/28/2008 | CA2433765C Use of botulinum toxin for treatment of articular pathologies |
| 10/28/2008 | CA2373868C Compositions comprising organosiloxane resins for delivering oral care substances |
| 10/28/2008 | CA2357251C Method and agent for enhancing diffusivity and long-lasting property of fragrance |
| 10/28/2008 | CA2337227C Emollient esters based upon capryl alcohol and isostearic acid |
| 10/28/2008 | CA2335472C Processes to generate submicron particles of water-insoluble compounds |
| 10/28/2008 | CA2315767C Autoclavable pharmaceutical compositions containing a chelating agent |
| 10/28/2008 | CA2225924C Recombinant mistletoe lectin |
| 10/28/2008 | CA2203456C Topical analgesic composition |
| 10/28/2008 | CA2170748C Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
| 10/28/2008 | CA2145302C Peptide proteinaceous drug nasal powder composition |
| 10/27/2008 | CA2586748A1 Agents for prophylaxis or treatment of neurological diseases and conditions |
| 10/25/2008 | CA2587805A1 Improved vitamin d content uniformity in pharmaceutical dosage forms |
| 10/23/2008 | WO2008127827A1 Health bars and compositions for improving mental and physical energy |
| 10/23/2008 | WO2008127609A1 Melatonin tablet and methods of preparation and use |
| 10/23/2008 | WO2008127532A1 Novel strategies for delivery of active agents using micelles and particles |
| 10/23/2008 | WO2008126846A1 Antibacterial agent for vancomycin-resistant gram-positive bacterium |
| 10/23/2008 | WO2008126797A1 Method for producing pulverized organic compound particle |
| 10/23/2008 | WO2008126782A1 Antiseptic agent for skin |
| 10/23/2008 | WO2008126720A1 Suspension for visualization of transparent tissue in eye |
| 10/23/2008 | WO2008125800A2 Mmp activated vascular disrupting agents |
| 10/23/2008 | WO2008125240A2 Method for producing storage-stable solutions from pelargonium extracts |
| 10/23/2008 | WO2008109230A3 Therapeutic composition with enhanced endothelium targeting |
| 10/23/2008 | WO2008066507A3 Nanotube devices for targeted delivery of therapeutic molecules |
| 10/23/2008 | WO2008063839A3 Targeted delivery of therapeutic agents with lyophilized matrices |
| 10/23/2008 | WO2008053330A3 Monoclonal antibodies against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 10/23/2008 | WO2008023277A3 Compositions containing coenzyme q-10 and dihydrolipoic acid |
| 10/23/2008 | WO2007134245A3 Elastin-like polymer delivery vehicles |
| 10/23/2008 | WO2007095746A9 Cancerous disease modifying antibodies |
| 10/23/2008 | WO2007054818A3 Foamable vehicle and pharmaceutical compositions thereof |
| 10/23/2008 | WO2007022254A3 Pharmaceutical formulations for sustained drug delivery |
| 10/23/2008 | US20080263607 Downloading and Transfer of Audio or Video Data from Video Broadcasts |
| 10/23/2008 | US20080262444 Percutaneously Absorbable Preparation, Percutaneously Absorbable Preparation Holding Sheet, and Percutaneously Absorbable Preparation Holding Equipment |
| 10/23/2008 | US20080262210 Immunostimulating Agents |
| 10/23/2008 | US20080262166 Controlling hydrolysis stability of polymer; reacting polyether with n,n'-dicyclohexylcarbodiimide |
| 10/23/2008 | US20080262155 Superabsorbent polymers, preparation thereof and use thereof |
| 10/23/2008 | US20080262108 Screening for active modulators with binding affinity of Carboxyl Ester Lipase(CEL)(cholesterol esterase) to receptors for the prevention/treatment of atherosclerosis; immunohistochemistry; screening/biological/; reducing the retention of atherogenic lipoproteins in atherogenesis; mechanism of action |
| 10/23/2008 | US20080262107 Pharmaceutical Compositions With Enhanced Performance |
| 10/23/2008 | US20080262106 Direct Compressible Trehalose Solids |
| 10/23/2008 | US20080262105 Matrices for time release drug systems of a biodegradable addition-condensation copolymer including polyesters and polylactones; star, comb and graft polymers; proteic drugs affinity to prevent "out-burst" pharmacokinectics; completely bioeliminable; non-toxic; thin layers, needles, micro/nanospheres |
| 10/23/2008 | US20080262104 Free-radically polymerizing vinyl acetate and 0.05-5 % acrylic acid and/or methacrylic acid in the presence of aminimal amount (0.001 to 1%) of ionic emulsifier/surfactant; dispersions and powders for pharmaceuticals/cosmetics; sustained release agents; film-coated tablets; shelf life; protective colloid |
| 10/23/2008 | US20080262102 Biodegradable polymer scaffolds for skeletal reconstruction; hydrogels with controllable hydrophilicity, swelling, mechanical properties; biocompatible, bioresorbable, injectable, and in-situ hardening; tissue engineering and controlled drug release; photocrosslinking; surgerical handling/positioning |
| 10/23/2008 | US20080262100 Dissolve a carrier and "dopant" in the continuous phase or disperse phase, respectively, in an oil in water or water in oil emulsion; cool to solidify carrier/continuous phase; vaporize water and volatile second phase; at room temperature obtain liquid with "dopant" uniformly dispersed; cosmetics; drug |
| 10/23/2008 | US20080262091 Analgesic/antinociceptive agents comprising 1-15,000mu g of capsaicin and other capsaicinoids in a vehicle; side effect reduction; neuropathic pain; neurotransmitter-dysregulation syndromes; incapacitation of C-fibers and/or A-delta fibers; denervate edges without eliciting an effect outside the edge |
| 10/23/2008 | US20080261960 Photosensitizers for photodynamic therapy; killing tissue, cells; anticancer agents |
| 10/23/2008 | US20080261942 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 10/23/2008 | US20080261927 Nutrient phytosterol or phytostanol ester with dispersion aid selected from triglyceride, an essential oil extract, night primrose oil, and/or fish oil; beverages, cosmetics |
| 10/23/2008 | US20080261914 Stabilization of vitamin b12 |
| 10/23/2008 | US20080261877 Albumin Fusion Proteins |
| 10/23/2008 | US20080261863 Pegylation of Vasoactive Intestinal Peptide (Vip) / Pituitary Adenylate Cyclase Activating Peptide (Pacap) Receptor 2 (Vpac2) Agonists and Methods of Use |
| 10/23/2008 | US20080261303 Method and medicament for inhibiting the expression of a given gene |
| 10/23/2008 | US20080261245 Antibodies, including fv molecules, and immunoconjugates having high binding affinity for mesothelin and methods for their use |
| 10/23/2008 | US20080260871 Method and composition for infusing herbal extracts and pharmaceuticals through the skin |
| 10/23/2008 | US20080260868 Folate based composition for neurological and cognitive applications |
| 10/23/2008 | US20080260850 Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative |
| 10/23/2008 | US20080260846 Has acceptable biodegradable polymer; polyglycolic acid, polylactic acid; Parkinson's Disease; injectable microspheres, injectable gels and implants; enhanced bioavailability |
| 10/23/2008 | US20080260842 Permeation enhancing compositions for anticholinergic agents |
| 10/23/2008 | US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent |
| 10/23/2008 | US20080260835 Bioavailability; solid dispersion; dosage forms |
| 10/23/2008 | US20080260814 Minimizing plant contamination; high throughput; fracture and streaking prevention; heat resistant moldings; including devolatilization step |
| 10/23/2008 | US20080260813 Pharmaceutical composition of topiramate |
| 10/23/2008 | US20080260805 Water degradation; controlled drying; digestible film containing water soluble polymer |
| 10/23/2008 | US20080260795 Water gellant containing polymer with hydrogen bonding; hydrophobic linkage |
| 10/23/2008 | US20080260793 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof |
| 10/23/2008 | US20080260791 Reducing pain; in situ administering dosage |
| 10/23/2008 | US20080260770 Use of Tellurium Compounds as Adjuvants |
| 10/23/2008 | US20080260768 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 10/23/2008 | US20080260757 Bispecific Fusion Antibodies With Enhanced Serum Half-Life |
| 10/23/2008 | US20080260733 Humanized collagen antibodies and related methods |
| 10/23/2008 | US20080260685 Prodrugs of cc-1065 analogs |
| 10/23/2008 | US20080260677 Transdermal Topical Composition and Its Uses |